
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Reserpine
- Form
- Tablet
- Strength
- Reserpine 0.1MG · Reserpine 0.25MG · Reserpine 0.2MG/4ML · Reserpine 1MG
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- hypertension, schizophrenia, dyskinesias
- Manufacturer
- Novartis
- FDA application
- NDA009115
- Availability
- Discontinued (per FDA)
May treat (source: NIH RxClass)
- hypertension
- schizophrenia
- dyskinesias
Dosage forms
Tablet
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Serpasil treat?
- Serpasil (Reserpine) may be used to treat hypertension, schizophrenia, dyskinesias, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Serpasil rated?
- pharmaranks gives Serpasil a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Serpasil?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Serpasil. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Serpasil?
- Serpasil is marketed by Novartis. You can see Novartis's full profile, rating, and other products on pharmaranks.
- Is Serpasil a brand-name or generic drug?
- Serpasil is a brand-name product with the active ingredient Reserpine. Lower-cost generic equivalents containing Reserpine are available — ask your pharmacist.
- Is Serpasil available over the counter?
- No. Serpasil is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Serpasil come in?
- Serpasil is currently marketed as tablet, per the FDA's National Drug Code Directory.
- Is Serpasil FDA-registered?
- Serpasil is on record with the U.S. FDA under application number NDA009115. You can verify this on its official FDA label.
- Has Serpasil been recalled by the FDA?
- Serpasil has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Serpasil safe?
- There's no single safe-or-not verdict. pharmaranks gives Serpasil a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about RESERPINE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 235 reports naming RESERPINE — the active ingredient in Serpasil, and the FDA flagged 84% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- gastrointestinal haemorrhage15 reports
- hypoglycaemia15 reports
- shock15 reports
- dyspnoea14 reports
- dizziness13 reports
- multiple organ dysfunction syndrome13 reports
- nausea12 reports
- fatigue11 reports
Read these as a signal, not a rate. A report does not mean RESERPINE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
amlodipine besylate
Amlodipine Besylate
aristada
Aripiprazole Lauroxil
aristada initio kit
Aripiprazole Lauroxil
atacand
Candesartan Cilexetil
bumex
Bumetanide
cardene
Nicardipine Hydrochloride
Compare Serpasil head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
serpasil
70/100